ebook Munafa Stock Market Course + Intraday & FNO calls  

       

BBIO announcements Bridgebio Pharma Inc announcements and dividends declared NASDAQ

Bridgebio Pharma Inc Complete list of announcements declared & dividend announcements by Bridgebio Pharma Inc BBIO

Bridgebio Pharma Inc BBIO listed on NASDAQ and deals in

Announcements and dividends declared by Bridgebio Pharma Inc BBIO

BridgeBio Pharma Presents Positive Data From CANaspire Phase 1/2 Study In Canavan Disease
(RTTNews) - BridgeBio Pharma, Inc. (BBIO) Thursday reported positive preliminary data from the CANaspire Phase 1/2 study of its gene therapy candidate, BBP-812 for the treatment of Canavan disease, a rare genetic neurological disorder.
Announcement as on 24 October 2024

Oppenheimer Initiates Coverage of BridgeBio Pharma (MUN:2CL) with Perform Recommendation
Fintel reports that on October 3, 2024, Oppenheimer initiated coverage of BridgeBio Pharma (MUN:2CL) with a Perform recommendation.
Announcement as on 06 October 2024

BridgeBio Pharma Commences Public Offering Of 0 Mln Of Shares; Stock Down
(RTTNews) - BridgeBio Pharma Inc. (BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, said that it has commenced an underwritten public offering of 0 million of shares of its common stock.
Announcement as on 05 March 2024

: BridgeBio Pharma shares gain on trial results for dwarfism drug
Shares of BridgeBio Pharma Inc. BBIO gained 5.5% premarket on Tuesday after the company announced that its investigational treatment for children with achondroplasia, a bone growth disorder that causes disproportionate short stature, resulted in significan
Announcement as on 20 June 2023

BridgeBio Pharma (BBIO) Gains As Market Dips: What You Should Know
BridgeBio Pharma (BBIO) closed the most recent trading day at .02, moving +0.1% from the previous trading session. The stock outpaced the S&P 500's daily loss of 2.77%. Elsewhere, the Dow lost 2.82%, while the tech-heavy Nasdaq lost 0.83%.
Announcement as on 22 April 2022

Announcements by Bridgebio Pharma Inc first page | Next page |

BBIO Bridgebio Pharma Inc current price & indicator signals

Moving Averages for Bridgebio Pharma Inc

  • 5Day Average: 73.16
  • 12Day Average: 70.78
  • 20Day Average: 68.54
  • 50Day Average: 61.6
  • 100Day Average: 55.55
  • 150Day Average: 50.07
  • 200Day Average: 46.06

BBIO Indicators & signals

Indicator MACD (12,26,9)

71.14, 67.58, 3.29
Indicator MACD is in positive zone

Indicator ADX (14)

62.22, 28.19, 6.56
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 66
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of BBIO Bridgebio Pharma Inc are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 73.64 72.38 to 74.86 -1.5% 0.85 times
04 Thu Dec 2025 74.76 72.48 to 75.04 0.82% 0.59 times
03 Wed Dec 2025 74.15 71.16 to 74.34 3.76% 0.9 times
02 Tue Dec 2025 71.46 71.35 to 73.45 -0.45% 0.95 times
01 Mon Dec 2025 71.78 71.07 to 72.47 -0.32% 1.05 times
28 Fri Nov 2025 72.01 70.93 to 72.28 0.4% 0.23 times
26 Wed Nov 2025 71.72 70.10 to 72.26 1.54% 0.76 times
25 Tue Nov 2025 70.63 69.53 to 71.65 -0.51% 0.82 times
24 Mon Nov 2025 70.99 67.92 to 71.43 4.23% 1.98 times
21 Fri Nov 2025 68.11 64.41 to 69.40 5.4% 1.81 times
20 Thu Nov 2025 64.62 64.47 to 67.25 -1.4% 0.9 times
19 Wed Nov 2025 65.54 64.50 to 65.96 -0.08% 0.56 times

Videos related to: BBIO announcements Bridgebio Pharma Inc announcements and dividends declared NASDAQ

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

BBIO announcements Bridgebio Pharma Inc announcements and dividends declared NASDAQ

 

Back to top